## Amaero Launches A$50 Million Capital Raise to Accelerate Defense Manufacturing Expansion
Amaero Ltd (ASX:3DA, OTCQB: AMROF), a major U.S. manufacturer of high-performance C103 and titanium alloy powders for defense and aerospace applications, has moved swiftly to capitalize on accelerating demand for domestic manufacturing capabilities. The company has secured firm commitments to issue 125 million new shares at A$0.40 each, generating A$50 million in gross proceeds (roughly US$32.3 million before costs) while simultaneously opening a A$3 million shareholder purchase plan for existing investors at the same price.
**Why the Rush to Raise Capital Now?**
Though Amaero had adequate funding to execute its A$72 million capital spending roadmap and reach EBITDA profitability by FY2027, strong investor appetite for re-shoring and defense supply chain strengthening prompted the board to accelerate its timeline. The company has already deployed approximately A$70 million in cash and tangible assets over the past three years following A$98.5 million in total capital raises, establishing itself as a first-mover in sovereign manufacturing for high-grade alloy powders.
**What's Next for Amaero?**
The fresh capital will fund several growth initiatives originally scheduled for later in the decade. Priority investments include ordering a fourth atomizer unit by year-end, building an argon gas recycling system, and pursuing additional corporate development opportunities. These moves position Amaero to expand production capacity while maintaining its competitive cost advantage in serving defense, space, aviation, and medical sectors.
**The Placement Terms**
Amaero's 125 million new shares represent a 15.7% dilution to current issued capital. The A$0.40 issue price sits 5.9% below the previous closing price of A$0.425 and a 15.8% discount to the five-day volume-weighted average price of A$0.475 through August 19. Barrenjoey Markets and Curran & Co are acting as joint lead managers. All new shares rank equally with existing shares from issuance.
**Timeline for Shareholders**
Settlement of placement shares occurs August 27, with trading commencing August 28. The shareholder purchase plan opens August 29 and closes September 19, with participants capped at A$30,000 per application. Final SPP results and new share issuance are expected by September 26, with trading starting September 29.
**A Strategic Positioning Play**
Amaero's three-year journey from capital deployment to commercialization has positioned the company at the intersection of U.S. policy priorities around defense industrial base resilience and supply chain re-shoring. Management emphasized that this raise reflects confidence in the long-term opportunity and the company's disciplined approach to capital allocation—not urgency around cash needs.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
## Amaero Launches A$50 Million Capital Raise to Accelerate Defense Manufacturing Expansion
Amaero Ltd (ASX:3DA, OTCQB: AMROF), a major U.S. manufacturer of high-performance C103 and titanium alloy powders for defense and aerospace applications, has moved swiftly to capitalize on accelerating demand for domestic manufacturing capabilities. The company has secured firm commitments to issue 125 million new shares at A$0.40 each, generating A$50 million in gross proceeds (roughly US$32.3 million before costs) while simultaneously opening a A$3 million shareholder purchase plan for existing investors at the same price.
**Why the Rush to Raise Capital Now?**
Though Amaero had adequate funding to execute its A$72 million capital spending roadmap and reach EBITDA profitability by FY2027, strong investor appetite for re-shoring and defense supply chain strengthening prompted the board to accelerate its timeline. The company has already deployed approximately A$70 million in cash and tangible assets over the past three years following A$98.5 million in total capital raises, establishing itself as a first-mover in sovereign manufacturing for high-grade alloy powders.
**What's Next for Amaero?**
The fresh capital will fund several growth initiatives originally scheduled for later in the decade. Priority investments include ordering a fourth atomizer unit by year-end, building an argon gas recycling system, and pursuing additional corporate development opportunities. These moves position Amaero to expand production capacity while maintaining its competitive cost advantage in serving defense, space, aviation, and medical sectors.
**The Placement Terms**
Amaero's 125 million new shares represent a 15.7% dilution to current issued capital. The A$0.40 issue price sits 5.9% below the previous closing price of A$0.425 and a 15.8% discount to the five-day volume-weighted average price of A$0.475 through August 19. Barrenjoey Markets and Curran & Co are acting as joint lead managers. All new shares rank equally with existing shares from issuance.
**Timeline for Shareholders**
Settlement of placement shares occurs August 27, with trading commencing August 28. The shareholder purchase plan opens August 29 and closes September 19, with participants capped at A$30,000 per application. Final SPP results and new share issuance are expected by September 26, with trading starting September 29.
**A Strategic Positioning Play**
Amaero's three-year journey from capital deployment to commercialization has positioned the company at the intersection of U.S. policy priorities around defense industrial base resilience and supply chain re-shoring. Management emphasized that this raise reflects confidence in the long-term opportunity and the company's disciplined approach to capital allocation—not urgency around cash needs.